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Objective: Some IBS patients possess detailed memories of the events surrounding
their bowel symptom onset (“episodic memories”). In this exploratory study we
sought to: (1) examine memory relationship with gastrointestinal (GI) symptom severity,
extraintestinal symptoms, and mood; (2) qualitatively explore memory valence and
content in IBS patients with or without episodic memories.
Methods: Referral IBS patients n = 29; age 47.0± 2.2 years, 79.3% female)
enrolled in this cross-sectional, mixed methods research study. Participants completed
validated specific memory instruments [Autobiographical Memory Test (AMT), Sentence
Completion for Events from the Past Test (SCEPT)] and relevant questionnaires [IBS
symptoms 10-cm visual analog scale); SF-36 Health-related quality of life (HRQOL);
Perley-Guze and PHQ-15/12: somatization; Beck Depression/Anxiety Inventories).
Qualitative analysis examined the content and valence of general memories.
Results: 14/29 (48.3%) of IBS subjects endorsed episodic memories of IBS symptom
onset, often GI infections/enteritis (35.7%). Recall of the exact year (69%) and month
(60%) of symptom onset were common. Episodic memories were associated with greater
IBS symptom severity/bother, higher anxiety/depression, and poorer HRQOL. Though
AMT and SCEPT memory specificity were not different based on episodic memories,
overgeneralization to negatively-valenced cues in the AMT was associated with more
severe IBS in those without episodic memory. Qualitative analysis revealed no observable
differences in topic focus of IBS patients with and without episodic memories.
Conclusions: IBS patients often endorse episodic memories associated with symptom
onset, and this recall seems to associate with more severe symptoms. Overgeneralization
responses to negative stimuli may lead to worse bowel symptoms in those without
episodic memories. IBS memory specificity may associate with qualitative differences
in processing psychosocial experiences and might be important to IBS pathophysiology.
Keywords: irritable bowel syndrome, memory, abdominal pain, somatization, anxiety, depression
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INTRODUCTION

responses to validated autobiographical memory questionnaires
and interviews.

Irritable bowel syndrome (IBS) is a heterogeneous
gastrointestinal (GI) condition characterized by abdominal
pain and associated alteration in stool frequency and consistency
(1, 2). As a result of this recognized lack of uniformity in IBS,
numerous attempts have been made to identify relevant IBS
subgroups. Despite these efforts, no satisfactory subclassification
has emerged to date. Most commonly, subclassification is defined
by bowel pattern (constipation, diarrhea, mixed) though this has
been useful mostly for developing pharmacotherapies targeted at
alterations in intestinal motility and/or secretion (3). Moreover,
these subgroups have never been fully validated clinically, in part
because the classification can change during the course of the
illness (4, 5) and in part because the definition of these subgroups
does not reflect the fact that a distinctive bowel pattern, and
likely is not the only important factor defining symptomatology
in many IBS patients (6).
Other IBS subclassification schemes, such as grouping
according to documentation of comorbid psychiatric diagnoses
(7), or expression of current anxiety or depression symptoms
(8, 9), also have been suggested. Although the association of
psychiatric disorders and symptoms with IBS is well documented,
clinical significance of this relationship remains unclear. While
patients seen in psychiatric clinics often report symptoms that
meet the diagnostic criteria for IBS, such bowel symptoms may
not be of primary concern to the patient (10). At the same
time, historical psychiatric disorders and current symptoms often
accompany IBS when the latter disorder is the primary problem.
In such cases, the psychiatric comorbidities presumably modify
the response to IBS symptoms (9, 11). IBS patients with higher
psychiatric burdens do endorse more severe symptoms and
poorer health-related quality of life in referral populations (10).
During the clinical care of patients with IBS, two of the
authors (GS and DHA) have noted that many patients provided
histories of a specific event at the onset of their IBS symptoms.
This observation raised the possibility that the response to, or
memory of, symptom onset might have mechanistic relevance
to the initial development, and propagation of, IBS symptoms in
such individuals. Further, we hypothesized that the presence or
absence of such “specific memories” might serve as an important,
meaningful way of subgrouping IBS patients, and might be
of phenotypic relevance (i.e., IBS symptom severity, non-GI.
Indeed, memory specificity has demonstrated significance in
mood disorders, such as depression, that often accompany
IBS (12).
We proposed that exploring aspects of the response to,
and recall of, IBS symptoms (i.e., the “experience of illness”)
might be relevant to the heterogeneity of IBS presentations.
Moreover, such an approach may eventually provide clues
regarding the pathogenesis, clinical course, and perhaps even
the optimal treatment of the IBS patient. Thus, we conducted
an exploratory study to measure and stratify IBS patients for
the presence or absence of a specific disease-initiating memory,
with the intention of comparing the groups in terms of IBS
symptom measures, as well as quantitative and qualitative
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METHODS
Subjects and Clinical Characteristics
Adult IBS patients (≥18 years old) presenting for care at
a tertiary outpatient gastroenterology practice of one of the
investigators were invited to participate in this cross-sectional
study between March 1, 2014 and December 31, 2014. The study
subjects completed comprehensive symptom questionnaires,
assessing GI symptoms, non-GI somatization symptoms, mood,
and health-related quality of life, including the: (1) Rome III
Research Diagnostic Questionnaire (13), (2) Beck Depression
Inventory (BDI), (3) Beck Anxiety Inventory (BAI), (4) Patient
Health Questionnaire (PHQ15) somatization scale, and (5) SF36 HRQOL index (detailed below). Rome III criteria were
applied to confirm the clinical features of IBS in this patient
group, as only subjects satisfying these IBS criteria were included
in the interview phase of the study. Baseline demographic
characteristics, including sex and age, were recorded for all
participants. Written informed consent was obtained from
all study participants prior to collection of medical history
or clinical data. Study protocol approval by the Washington
University School of Medicine Human Research Protection
Office (Institutional Review Board) was obtained prior to
study initiation.

Study Instruments
Bowel Symptoms
GI symptom severity and bother were assessed using 10-cm visual
analog scales (VAS), as previously described (10). Specifically,
the questions queried: “When you have your gastrointestinal
symptoms, how severe are they?” (0 = “not severe at all”,
10 = “extremely severe”) and “How much have you been
bothered overall by your gastrointestinal symptoms over the
preceding 2 weeks?” (0 = “not bothered at all”, 10 = “extremely
bothered”). Previously these VAS symptom severity scores were
demonstrated to correlate in a statistically significant manner
with disease-specific instruments such as the Gastrointestinal
Symptom Rating Scale-IBS (GSRS-IBS) (Pearson r = 0.52, p
< 0.0001) (14). Frequency of GI symptoms (e.g., number of
symptomatic days) in the previous 2 weeks also was recorded
(from 0 to 14 days).

Psychological and Somatization Assessments
The Beck Depression Inventory (BDI) and Beck Anxiety
Inventory (BAI) were used to evaluate the presence of
recent mood symptoms. Each instrument is a self-reported
21-question, multiple-choice inventory validated to assess
characteristic attitudes and symptoms of depression and
anxiety, respectively (15–17). Although these depression
and anxiety inventories are intended to detect current
symptom burden and alone are insufficient to make
psychiatric diagnoses, they do indeed correlate with lifetime
diagnoses (18, 19).
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An additional method of assessment of memory specificity
was the Sentence Completion for Events from the Past Test
(SCEPT), an 11-item instrument which provides sentence stems,
and instructs the participant to “complete each of the sentences”
(28). A sample item is “I still remember well how. . . ”. In contrast
to AMT, the SCEPT stems all are valence neutral.
The AMT and SCEPT further were coded into described,
validated categories by one of the investigators (BG) not involved
in the patient care, and blinded to the clinical data. These
responses were designated as one of the six following pre-defined
categories: (1) specific memory, “referring to one specific moment
or a particular time, e.g. ‘How sad I was the day my grandfather
died.”’; (2) categoric memory, “a repeated activity or a category
of events without the specification of a particular time, e.g., ‘My
grandmother used to play games with me when I was little.”’; (3)
extended memory, “refers to an extended period of time which
lasted more than one day, e.g., ‘I was ill for two weeks in a row last
year,”’; (4) semantic associate, “referring to personal overgeneral
semantic information, e.g., ‘I used to be a very shy girl.”’; (5)
omission, in the event that the subject could either not generate
a response or “did not seriously try to complete the response in a
meaningful way”. Individuals’ responses were then dichotomized
as “specific memories” (category 1) or “overgeneral memories”
(categories 2–5) (28).
Non-psychotic formal thought disorder (NFTD or NPFTD)
was assessed in 27 categories of thought disorder (e.g., “vague”,
“flippant”, “circumstantial”) by coding transcribed patient
narratives from assessment of the AMT, and SCEPT. All of the
NFTD ratings were performed by a single expert physician (CN)
blinded to group assignment (11, 29).

The Patient Health Questionnaire (PHQ-15) is a self-reported
inventory validated to assess for somatic symptom severity, with
higher PHQ-15 scores approximating somatization (somatic
symptom) disorder diagnoses (20). The PHQ-12 measures
non-GI somatic symptoms in functional GI disorder (FGID)
patients, excluding the PHQ-15 GI symptoms (“stomach pain”,
“constipation, loose bowels, or diarrhea”, and “nausea, gas, or
indigestion”) (10).
The Perley-Guze criteria were utilized as well-validated,
comprehensive criteria for the diagnosis of somatization disorder
(21–23), though Perley-Guze criteria do not translate into a
DSM-5 diagnosis of somatic symptom disorder. The PerleyGuze symptom checklist assesses 59 different symptoms across
10 possible symptom groups. Only symptoms that are clinically
relevant (result in “a lot of trouble”) and are without a medical
explanation are counted as Perley-Guze symptoms. A PerleyGuze diagnosis of somatization requires the presence of >
25 symptoms distributed among > 9 of 10 possible symptom
categories (20).

Health-Related Quality of Life (HRQOL)
The SF-36 is a validated assessment of health-related wellbeing
and functional status. SF-36 measures HRQOL as an overall
(global) score, and further can be subdivided into physical and
mental component summary scores, gauging the influence of
the individual’s medical conditions on physical and emotional
wellbeing and limitation of day-to-day and pleasurable activities
(24). The SF-36 measures HRQOL along a scale of 0 to 100,
with higher scores reflecting better quality of life; it is one of the
most widely used generic health outcome assessment measures,
and has been applied to the study of a multitude of diseases and
conditions (25).

Statistical Analysis
Quantitative Methods
This study was analyzed with mixed methods approach. Grouped
values were reported as mean ± standard error of mean for
continuous variables, or median and range values for categorical
variables. Between-group comparisons were performed using
Student’s t-tests, and Chi-square analyses were performed
for binomial data as appropriate. In each case, p < 0.05
was required for statistical significance, with an assumption
of unequal variances. In order to explore the relationship
between specificity of memory and the clinical presentation
of the IBS and related non-GI (somatization) symptoms,
correlational analyses were performed with generation of
Pearson correlation coefficients. Given the exploratory nature
of this study, no adjustments for multiple comparisons were
implemented. All of the reported statistical analysis was
carried out using SPSS Statistics version 27 (IBM SPSS,
Armonk, NY, USA and SAS version 9.4 (SAS Institute, Cary,
NC, USA).

Memory Assessments
IBS subjects all were interviewed by a single physician
investigator (AS) who queried them about their recollection of GI
specific memories. The interviews were recorded and transcribed
by a third party not involved in the research study. They were
asked, “Do you have a recollection of a specific event occurring at
the time of your symptoms onset?” This question was recorded
in a yes/no fashion, and served as the basis for dichotomizing
the IBS study subjects into those with and without GI specific
memories. Furthermore, subjects were asked to recall “What year
did your symptoms begin?” and in the event that they were
able to recall the year, a follow-up question: “Do you remember
what month your symptoms began?”. Those subjects with a GI
specific memory also were asked about “What specific details
you can recall about the event?” surrounding the onset of their
IBS symptoms.
The second portion of the interview involved the
Autobiographical Memory Test (AMT) (26), asking participants
to produce a specific memory in response to a cue word
presented by the interviewer within a 60-s time limit. The 10
cue words had clear emotional valence, including five positive
words (i.e., happy, safe, interested, successful, surprised) and five
negative words (i.e., sorry, angry, clumsy, hurt, lonely) (27).
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Qualitative Methods
Qualitative data on memory of onset of IBS, and autobiographical
memories in relation to 5 positively and 5 negatively valenced
emotions and memories of past events were collected in an audiorecorded interview by a physician on the investigative team.
These interviews were transcribed and the collective content
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Memory Assessments

from all of the patients was subjected to qualitative analysis. To
begin the qualitative analysis, one researcher (GS) read all of
the interview transcripts and identified a total of 30 categories
covering material from the AMT and SCEPT interviews. These
30 categories were then conceptually collapsed into four main
themes: (1) Vocation including work, school, money, and
material possessions; (2) Home Life and Relationships, including
family, friends, relationships, love, childhood, home, and pets; (3)
Health and Self, including medical and psychological content,
self, and medications/drugs; and (4) content External to Self,
including life events, politics, and entertainment. The number
of responses to the AMT and SCEPT items were coded into
the various themes and tabulated across the themes for each
interview. Interrater reliability was calculated for SCEPT rating
validity check for the instrument and was determined to be
very high, with Kappa = 0.913 95% CI 0.846–0.980); the
remainder of the coding was examined collaboratively by the
two qualitative coders (GS and BG). Following initial coding,
statistically significant results from the quantitative analysis were
used to guide an examination of qualitative content. The counts
of items coded in themes were compared with quantitative
variables collected in this study. Both the counts of items in
themes and the qualitative content within the themes were
examined for differences between IBS groups with and without
specific memories of their IBS onset.

Overall, the Autobiographical Memory Test revealed specific
memories in 16.6% of the responses across all the IBS
subjects (conversely overgeneral memories are documented
in 83.4% of cases) (Table 2). There were no significant
differences in AMT specific memories, either overall, or with
regard to cue word valence in the two IBS disease initiating
memory subgroups.
Twenty-six of the 29 (89.7%) subjects also participated
in the Sentence Completion for Events from the Past Test
(SCEPT). Here the overall rate of specific memories in the IBS
population was higher at 31.8%. However, again there were no
differences between the specific memory and no specific memory
IBS subgroups.

Correlation of Specific Memories and Clinical
Presentation
In order to explore the relationship between objective testing
detection of specific memories on the AMT and SCEPT,
correlation matrices were generated. In the AMT across the entire
IBS study population, greater overgeneralization of memories
suggested a relationship with more severe IBS symptoms and
greater numbers of IBS symptomatic days, as well as higher scores
on the PHQ-15 and PHQ-12, and worse HRQOL, particularly
on the SF 36 mental (Table 3, line 1). These observations were
driven particularly by the IBS subgroup with no specific memory
at symptom onset (Table 3, line 3). The relationships observed
were not particularly relevant in the AMT positive valence cues
among any of the IBS subgroups or the overall study population
(Table 3, line 4); rather, these effects appear to track most closely
in the negative valence AMT cues. Statistically significant positive
correlations in the overall IBS study population were observed
with regard to IBS severity and symptomatic days as well as the
PHQ-15 and PHQ-12, the BAI, and a negative correlation with
SF-36 total and SF-36 mental supplement domains (Table 3, line
7). As with the correlations of overgeneralization itself, these
correlations with negative valence cues were driven more by
the IBS subgroup with no specific memory at symptom onset
(Table 3, line 8). Examining the SCEPT, a positive correlation
was only detected with regard to overgeneral responses in
the total IBS population and symptoms on the Perley-Guze
inventory (r = 0.412, p = 0.045). Again, this appeared to
be predominantly driven by the IBS subgroups without recall
of a specific memory related to symptom onset (r = 0.485,
p = 0.11).

RESULTS
Quantitative Findings
Subject Demographics and Clinical Characteristics
A total of 29 IBS subjects (mean age 47.0 ± 2.2 years, 79.3%
female) agreed to participate in the study and completed
the baseline questionnaires and memory interview. Twenty
(69.0%) of the participants recalled the year of onset of
their symptoms, and 12/20 (60.0%) of these individuals
recalled the specific month of their symptom development.
Of the overall IBS subject population, 14 (48.3%) endorsed a
memory of a specific “disease initiating” event in association
with the onset of their IBS symptoms. The most common
experiences recalled at the time of IBS symptom onset
included symptoms consistent with infection (5/14, 35.7%),
psychological stress, and a recent surgery (4/14, 28.6% for
each, respectively).
In comparing the subjects reporting a specific memory
in association with their IBS symptom onset, there were no
differences demographically (Table 1). However, subjects with
a specific disease initiating memory did report greater IBS
symptom bother and endorsed more severe symptoms. This same
cohort also was found statistically to have significantly higher
anxiety scores (BAI) and trends toward greater recent depression
symptoms (BDI). Further, the specific memory participants had
higher recent non-GI somatoform symptoms on the PHQ-12, but
did not have any detectable difference in medically unexplained
symptoms or symptom groups on the Perley-Guze assessment.
IBS patients with a specific memory trended toward poorer
overall HRQOL, as well as statistical significance for lower
physical and mental HRQOL.
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Qualitative Findings
Although the quantitative responses did not separate the
groups with and without a disease-initiating memory, qualitative
differences between these two groups were observed in
two of the four themes (Home Life and Relationships and
content External-to-Self). For the IBS group without a diseaseinitiating memory, somatoform characteristics were statistically
significantly associated with the amount of specific topical
memory content generated for the two themes. Greater content
in the AMT Home Life and Relationships theme was positively
associated with somatoform characteristics (level of NFTD:
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TABLE 1 | Baseline demographic and clinical characteristics.
Variable*

All IBS subjects (n = 29)

No specific memory (N = 15)

Specific memory (N = 14)

P value
0.18

Mean age (years)

47.0 ± 2.2

44.4 ± 3.9

50.4 ± 3.2

Female gender (%)

23 (79.3%)

13 (86.7%)

10 (71.4%)

0.31

IBS Symptom severity (VAS)

6.6 ± 0.6

5.8 ± 0.8

7.8 ± 0.4

0.057

IBS Symptom bother (VAS)

6.5 ± 0.6

5.6 ± 0.8

7.9 ± 0.4

0.029

IBS Symptom Frequency (days in last 2 weeks)**

10 (1,14)

10 (1,14)

10 (2,12)

0.83

Beck Depression Inventory (BDI)

13.2 ± 1.5

11.2 ± 1.9

16.4 ± 2.1

0.08

Beck Anxiety Inventory (BAI)

12.2 ± 1.5

9.6 ± 1.3

16.2 ± 2.8

0.028

PHQ-15

12.3 ± 0.8

11.0 ± 1.0

16.4 ± 2.1

0.012

PHQ-12

7.8 ± 0.7

6.8 ± 0.9

9.4 ± 0.6

0.026

Perley-Guze symptoms

10.4 ± 1.1

10.6 ± 1.7

10.1 ± 1.4

0.84

Perley-Guze symptom groups

5.3 ± 0.5

5.4 ± 0.7

5.2 ± 0.6

0.82

SF-36 total

53.8 ± 5.0

60.9 ± 6.2

42.6 ± 6.4

0.059

SF-36 physical

48.3 ± 5.5

57.1 ± 6.5

34.6 ± 7.6

0.041

SF-36 mental

54.9 ± 4.7

59.4 ± 6.4

47.9 ± 6.1

0.021

*
**

Mean ± standard error of mean (SEM) unless otherwise noted.
Median (range).

TABLE 2 | Autobiographical memory test and sentence completion for events from the past test (SCEPT) by IBS subgroups.
Variable

All IBS subjects (n = 29)

IBS-No specific memory (N = 15)

IBS-Specific memory (N = 14)

P value

0.96

Autobiographical Memory Test (AMT)
Specific memory-total

48 (16.6%)

25 (16.7%)

23 (16.4%)

Overgeneral memory-total

242 (83.4%)

125 (83.3%)

117 (83.6%)

Specific memory-positive

22 (15.2%)

9 (12.0%)

13 (18.6%)

Overgeneral memory-positive

123 (84.8%)

66 (88.0%)

57 (81.4%)

Specific memory-negative

26 (17.9%)

16 (21.3%)

10 (14.3%)

Overgeneral memory-negative

119 (82.1%)

59 (78.7%)

60 (85.7%)

0.27
0.27

Sentence Completion for Events from the Past (SCEPT)
Specific memory

91 (31.8%)

43 (30.0%)

48 (33.6%)

Overgeneral memory

195 (68.2%)

100 (70.0%)

95 (66.4%)

0.53

Overgeneral memories, as recorded on the Autobiographical Memory Test (AMT) and Sentence Completion for Events from the Past Test (SCEPT) among the overall IBS cohort were
quantified as described in the Methods. These overgeneral memories (total, and by positive/negative valence on the AMT) were further correlated with these same clinical measures.

The two themes with associations between somatoform
characteristics and amounts of content in specific themes were
examined for their volume and content in the IBS groups with
and without a disease-initiating memory. The amount of total
content in the AMT Home Life and Relationships theme was
greater in the memory group (2,137 words) than in the nonmemory group (1,476 words). For this theme, the content of
the responses in the two groups, while different in amount of
detail, was relatively similar in terms of focus. For example,
content focused on both positive and negative events. In terms
of positive events, many individuals in both groups focused
on pregnancy and childbirth: for example, “Just having heard I
was going to have a baby was a surprise.” (memory) and “the
day my daughter was born was the first best day of my life!”
(no memory). In terms of negative events, individuals in both

r = 0.55, p = 0.034; number of functional disorders: r = 0.61,
p = 0.016). Greater content in the SCEPT External to Selftheme was negatively associated with somatoform characteristics
(number of somatoform symptoms: r = −0.90, p < 0.001;
number of positive somatoform symptom groups: r = −0.66,
p = 0.028). In contrast, focused examination of the IBS group
with a disease-initiating memory found that specific topical
memory content was not positively associated with number
of somatoform symptoms or symptom groups. Additionally,
the positive association of AMT Home Life and Relationships
with the number of functional disorders in the group without
a disease-initiating memory was statistically significant in the
opposite direction to the association with SCEPT Home Life and
Relationships (r = −0.62, p = 0.040) in the group with a diseaseinitiating memory.
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TABLE 3 | Correlation of overgeneral memories with ibs patient clinical characteristics, mood, and health related quality of life.
# P-G

# P-G

P-G,

IBS Sx

IBS Sx

IBS Sx

BAI

BDI

SF36

SF36

SF36

Sxs

groups

No GI Sx

severity

bother

days

PHQ15

PHQ12

total

total

total

physical

mental

Total AMT
Overgeneral, All
IBS Subjects

0.192

0.130

0.196

0.478

0.295

0.456

0.415

0.429

0.377

0.002

−0.371

−0.182

−0.475

Total AMT
Overgeneral,
IBS-No Specific
Memory

0.015

−0.085

0.131

0.716*

0.348

0.787*

0.596

0.495

0.596

0.203

−0.722*

−0.648

−0.71*

Total AMT
Overgeneral,
IBS-Specific
Memory

0.366

0.316

0.244

0.125

0.400

−0.070

0.254

0.499

0.304

−0.304

0.065

0.392

−0.157

Positive Valence
AMT Overgeneral,
All IBS Subjects

0.064

−0.031

0.097

0.131

0.062

0.198

0.024

0.064

0.020

−0.260

0.005

0.187

−0.156

Positive Valence
AMT Overgeneral,
IBS-No Specific
Memory

−0.096

−0.184

0.078

0.254

0.050

0.454

0.162

0.064

0.347

−0.093

−0.376

−0.304

−0.397

Positive Valence
AMT Overgeneral,
IBS-Specific
Memory

0.163

0.050

0.100

0.292

0.544

−0.117

0.117

0.363

0.005

−0.354

0.238

0.529

−0.024

Negative Valence
AMT Overgeneral,
All IBS subjects

0.308

0.266

0.288

0.534*

0.418

0.571*

0.709**

0.673**

0.618**

0.261

−0.586*

−0.458

−0.576*

Negative Valence
AMT Overgeneral,
IBS-No Specific
Memory

0.223

0.095

0.267

0.610

0.400

0.744*

0.741*

0.661*

0.603

0.265

−0.64*

−0.540

−0.624

Negative Valence
AMT Overgeneral,
IBS-Specific
Memory

0.482

0.544*

0.335

−0.213

−0.015

0.040

0.380

0.520

0.686

−0.089

−0.258

−0.008

−0.319

#P-G Sx, number of symptoms endorsed on Perley-Guze inventory; #P-G Groups, number of different Perley-Guze symptom groups; #P-G No GI Sx, number of symptoms endorsed
on Perley-Guze inventory, excluding GI symptoms.
Sx, symptoms; PHQ, Patient Health Questionnaire; BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory; SF-36, Short Form 36 Health related quality of life.
Pearson correlation coefficients reported.
* P<0.05; ** P<0.01.

groups). Individuals also mentioned more complex events, such
as moving: “Last year we moved to St. Louis” (memory).

groups focused on relationship-focused events, such as divorce—
“When I divorced my children’s mother was the worst period
of my life.” (memory), infidelity— “When my cousin had sex
with my husband, I was angry.” (no memory), and death— “I
am still hurting inside for not being able to talk to my mom
and dad since their death.” (memory), “I will never forget the
day we buried my grandmother” (no memory). Additionally, this
theme had similar negative and positive valence responses (33%
positive and 48% negative in the no disease-initiating memory
group and 22% positive and 49% negative in the disease-initiating
memory group).
For the External-to-Self theme, the two memory groups
were similar in content and detail, with the most frequent
responses focusing on past travel, both generically “In the past
I used to do a lot of world traveling to great and unusual
destinations” (no memory) and to a number of specific locations,
including Branson, Missouri, Las Vegas, and Los Angeles (both
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DISCUSSION
In this study, we identified that nearly one-half of IBS patients in
a tertiary gastroenterology referral center recall a specific event
in close association with the onset of their IBS symptoms. Some
potentially important clinical differences were found between
IBS subjects endorsing specific memories of such events, when
compared to patients without such memories. In particular,
patients with specific disease-associated memories had more
severe and bothersome IBS symptoms as compared to their
counterparts with no such memory. IBS patients with specific
memories also scored higher on measures of mood severity
(anxiety more so than depression) and somatoform symptoms,
and endorsed overall lower health related quality of life. In
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may have the same disease, no two illness experiences are the
same” (43). There exists a large literature on the experience
of illness, but that approach has not been widely applied to
IBS; however, the concept seems quite relevant. For example,
recent work suggested that IBS patients who develop severe
food avoidance and restriction may constitute a subgroup
with more severe symptoms and poorer HRQOL (44). It is
essential that the physician recognize that hidden behind the
façade of the disease and its diagnosis is a story, unique to
individual patients and their responses to the disease, or “illness
narrative”. From the current study, we discern that a substantial
percentage of IBS patients regard a specific event, such as an
infection, acute psychological stress, or a recent surgery as an
important part of this illness narrative with similar content of
the topics of their concerns, but with different emphasis of
content related to relationships and experiences external to self
in the two groups. Application of autobiographical memory
testing on an exploratory basis suggests such memories might
convey clinical relevance, including the experience of nonGI somatoform symptoms, particularly in an individual who
expresses overgeneralization in response to negative valence.
Strengths of this study included the examination of a
carefully phenotyped IBS patient population diagnosed by expert
gastroenterologists and verified using established diagnostic
criteria. Further, the evaluation of memory specificity in this
study relied upon the prospective collection of established
autobiographical memory instruments with scoring and
interpretation in a blinded fashion. This study was not without
limitations. Given the cross-sectional design of this investigation,
comments on causality cannot be offered. Further, without a
control population one cannot be certain that the observations
from the study are specific to IBS. The memory recall, in some
cases, dated back several years which could have influenced
the accuracy and influence on current symptoms. Further, the
study focus on a referral gastroenterology population limits
somewhat the generalizability of the results of the current trial to
community-based IBS populations at large Finally, our smaller
sample size in this exploratory study limited our ability to
conduct additional statistical analyses attempting to control for
some of the comorbid mood factors as potential confounders in
our results.
In summary, this exploratory study found that substantial
percentage of IBS patients endorse memories of a specific event at
the time of their symptom onset, a factor that may predict more
severe IBS symptoms, and perhaps non-GI comorbidities and
poor quality of life. Overgeneralization of memory, particularly
in relation to negatively valenced terms, too may portend
worse IBS symptoms in those without specific memories
relating to initiation of their symptoms. These preliminary
observations should inspire additional work to determine
whether these findings extrapolate to a broader IBS population,
and moreover to better understand the implications with regard
to clinical course and therapeutic outcomes. Longer term, it is
conceivable that these psychological factors could provide for
the identification of clinically-relevant IBS subgroups that benefit
from unique behavioral and pharmacotherapeutic approaches.

examining validated measures of memory specificity, overgeneral
responses on the Autobiographical Memory Test positively
correlated with symptoms of IBS, both severity and bother, as well
as poor health related quality of life. These observations appeared
to be driven by the negative valence cues of the AMT, especially
among the IBS patients with no specific memory. Thus, although
there were no observable differences in numeric representation of
the topics discussed by the IBS patients with and without specific
memories of their disease onset, content provided by those with
specific memories was positively associated with somatization
and functional disorders for home. These findings suggest
differences in IBS patients with and without specific memories of
disease onset in how they process their psychosocial experiences
of relationships and aspects of life external to themselves in
relation to their IBS.
Autobiographical memory and memory specificity has been
a topic of considerable interest in the psychiatric literature for
several decades. However, it remains an area of controversy,
with some studies failing to demonstrate a relationship between
memory specificity and recent mood (30, 31) while others
have suggested that depressive disorders may moderate the
individual’s memory specificity on autobiographical testing (32,
33). Interestingly, this compromise of memory specificity also
has been described in association following traumatic events and
posttraumatic stress disorder (34, 35), with abuse and trauma
experiences also commonly reported in IBS patient populations
(36, 37). These studies have not been designed to evaluate the
contribution of the entirety of comorbidities that may associate
with mood disorders, and to our knowledge there have been no
studies to date that have evaluated patient cohorts established on
the basis of medically unexplained, physical symptoms such as in
IBS, a disorder frequently found in association with depression
and/or anxiety. From a mechanistic perspective, it has been
suggested that memory overgeneralization may result from the
interaction of a ruminative focus on one’s self, impairments in
executive control, and a functional avoidance of memory retrieval
of aversive events as a protective mechanism that results in
distress reduction (12, 38, 39). With regard to mood, overgeneral
memories have been suggested to predict the clinical course of the
depressed patient, serving as a marker of treatment refractoriness
and suggested to be a trait marker for persistent depression (40).
The individual responses of IBS patients to their symptoms
of IBS likely has relevance to their symptom experience
and healthcare utilization 6, though such responses have not
been systematically studied. Attempts to account for patients’
responses to their symptoms have been made by examining
non-GI symptoms and healthcare utilization in addition to the
GI symptoms, but such efforts have not resulted in definable
subgroups of IBS patients (2, 6). Biomarkers also have been used
in attempts to identify patients with the presumed underlying
pathophysiology of visceral hypersensitivity, but without clear
results (41).
Illness behavior involves the response to illness by seeking
treatment, and is shaped by culture and expectations about how
to behave when ill also differ according to the patients’ unique
individual biographies (42). Thus, although “two individuals
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